AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03040271 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health-E-PALS-
Description: Intervention to promote Healthy Eating and Physical Activity in Lebanese School-Children It comprises in class-activities, meetings with parents, improvement of school food service
Study NCT03018314 — intervention group
Intervention type: OTHER
Intervention: Blood sample
Description: Serum analysis
Study NCT02133391 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Centralized Reminder/Recall (R/R)
Description: Method of increasing immunization delivery using reminder/recall techniques, which are implemented centrally.
Study NCT02133391 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Practice-based Reminder/Recall
Description: Method of increasing immunization delivery using reminder/recall techniques, which are implemented at the practice level.
Study NCT02365350 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: STEINER-TAN Needle®
Description: A purpose built new double lumen needle with little dead space.
Study NCT02365350 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 17 G single lumen needle
Description: A conventional single lumen IVF aspiration needle.
Study NCT03347383 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Combination therapy DCB + stent
Description: Patients will be treated with the Luminor DCB and iVolution stent
Study NCT03687983 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GoldenFlow Peripheral Stent System
Description: Performing anaesthetic and pathological angiography according to the standard method, and select appropriate stent specifications according to the contrast results. After 1:1 pre-expansion, the stent system will be imparted into the lesion location, the stent will be distally positioned and released. The Tip head will be reset and the conveyor will be removed. If necessary, local re-expansion can be carried out. Remove the catheter and suture the wound. Postoperative treatment and anticoagulation.
Study NCT02723188 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation (1.5 milliampere,30 seconds)
Study NCT02723188 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DC stimulation (1.5 milliampere, 20 minutes)
Study NCT02723188 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AC stimulation (1.5 milliampere,1.5 Hertz frequency)
Study NCT02182310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 201335 low dose
Study NCT02182310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 201335 placebo
Study NCT02182310 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BI 201335 placebo
Study NCT02182310 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin
Study NCT02182310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 201335 high dose
Study NCT04578704 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vacuum formed retainer, fixed bonded retainer, vacuum formed and fixed bonded retainer
Description: Patients will be instructed to wear the removable vacuum form retainer for 8 to 10 hours per day and only removed the retainers during tooth brushing. (Thickett 2010), (Gill 2007).~The vacuum formed retainer will be constructed using thermoplastic material that will be purchased from manufacturer at 1.0mm thickness.~Meanwhile, bonded retainer will be done using Ormco ® response deadsoft retainer wire size 0.190 round, made in USA by ORMCO Corporation, the fixed bonded wire will be extended distal to the extraction spaces that were previously closed by fixed appliances on both the upper and lower arches. The bonded retainer will be wearing by patients for 24 hours.~Double regime retainer that will be comprised of vacuum formed and bonded retainer will be constructed using the same properties as vacuum formed retainer and bonded retainer. A standard oral and written instruction will be given to patients regarding retainer's uses. (Shawesh M et.al, 2009).
Study NCT03925142 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Controlled healthy vegetarian diet
Description: The controlled healthy vegetarian diet will follow the Dietary Guidelines for American's recommendations. All foods and beverages will be provided during intervention to achieve the desired eating pattern.
Study NCT03925142 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled beef diet
Description: The controlled beef diet will incorporate various cuts of lean unprocessed red meat into the healthy vegetarian eating pattern, as approved by the American Heart Association's Food Certification Program. The beef diet will isocalorically replace starchy vegetables and/or refined grains with 6 oz. of beef/day for five weeks.
Study NCT04938076 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: Transcranial direct current stimulation on motor cortex
Study NCT04938076 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham control
Description: sham control
Study NCT03937115 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: 2 active tDCS sessions (20 min each, 2 mA) applied to the dlPFC and right motor cortex
Study NCT03937115 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: 1 sham tDCS session (20 min, 0 mA) applied to the dlPFC
Study NCT03937115 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: 10 tDCS sessions (2 sessions/day for 5 days, 20 mA, 20 min each) applied to the dlPFC
Study NCT03937115 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: 10 tDCS sessions (2 sessions/day for 5 days, 0 mA, 20 min each) applied to the dlPFC
Study NCT04265521 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biocool Footcare
Description: BioCool Footcare is a footbath containing granulate of sodium percarbonate that will in this study be used for treatment of foot fungus, heel cracks, calluses and/or dry feet.
Study NCT00732927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: parnaparin
Description: vials, 6.400 IU sc twice daily for 7 days, then once daily for a total of 3 months
Study NCT00732927 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aspirin
Description: tablets, 100 mg for 3 months
Study NCT04545801 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.25 mg/kg of Ketamine
Description: patients will recieve 0.25mg/kg of ketamine intravenously 5 min after spinal anesthesia
Study NCT04545801 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 20ml of normal saline solution
Description: 20ml of normal saline solution intravenously 5 minutes after spinal anesthesia
Study NCT00036764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ixabepilone
Description: Given IV
Study NCT00036764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacogenomic studies
Description: Correlative studies
Study NCT00036764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT04669431 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Xbox kinect Training
Description: Xbox kinect 360, Tennis player, Joy riding, Rally ball. Tennis player in first 2 weeks, Joy riding in 3rd and 4th weeks, and all 3 games in 5th and 6th weeks 35 minute/3 days a week for 6 weeks with Conventional physical therapy, 25 minute
Study NCT04669431 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conservative Rehabilitation
Description: Sustained Stretching, repetitive task training, activities of daily living( eating, grooming, folding of towel, basket lifting, turn key into lock, reaching forward, sideways reach, ball grasping, picking up small blocks and lifting cane and pencil) 35 minute/3 days a week for 6 weeks
Study NCT00962312 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine
Study NCT00962312 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lapatinib ditosylate
Study NCT01484951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brinzolamide 1% and timolol 0.5% fixed combination eye drops
Study NCT02224625 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2% CHG Cloth solution
Description: Investigational CHG
Study NCT02224625 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle Cloth
Description: Excipients from CHG cloth only
Study NCT02224625 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator
Description: Active comparator
Study NCT02224625 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Saline
Description: Negative control
Study NCT02224625 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SLS
Description: Provides a slight irritation for a positive control
Study NCT01980433 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Inhibitory 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.
Study NCT01980433 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Inhibitory 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.
Study NCT01980433 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pre and post-rTMS electroencephalogram
Description: to verify the absence of infraclinical seizures
Study NCT01980433 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: pre and post-rTMS electroencephalogram
Description: to verify the absence of infraclinical seizures
Study NCT01980433 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WCRS
Description: Writer's cramp rating scale
Study NCT01980433 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: WCRS
Description: Writer's cramp rating scale
Study NCT01980433 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: handwriting scale DPRE
Description: handwriting in development and being evaluated by the NRC Wilson
Study NCT01980433 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: handwriting scale DPRE
Description: handwriting in development and being evaluated by the NRC Wilson
Study NCT01980433 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: visual analog scale of discomfort writing and parameters collected on touchpad
Study NCT01980433 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: visual analog scale of discomfort writing and parameters collected on touchpad
Study NCT03278821 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self Match
Description: Video presentation of treatment option are shown to the patient whereafter the patient must choose between the five possible treatment options.
Study NCT03278821 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Expert Match
Description: Referral as usual to one of five possible treatment options. The referral is based on baseline data from the patient and by the means of an algorithm, used in daily clinical praxis.
Study NCT03593200 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegcetacoplan
Description: Complement (C3) Inhibitor
Study NCT04271124 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise training
Description: The patients are allocated to PR+ET group or PR Each group receive an exercise training
Study NCT04271124 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise training
Description: The patients are allocated to PR+ET group or PR Each group receive an exercise training
Study NCT01328639 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TeamCare Depression Intervention
Description: The TeamCare-PCN intervention involves a registered nurse Care Manager (CM), who coordinates collaborative team management for patients with diabetes and depression. The goal of the intervention is to reduce depressive symptoms, achieve targets for cardio-metabolic measures and improve lifestyle behaviours. The intervention includes three phases: (1) managing depression and improving depressive symptoms, (2) managing diabetes and controlling blood glucose, blood pressure and cholesterol, and (3) improving lifestyle behaviours such as healthy eating, physical activity and smoking cessation.
Study NCT01328639 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual diabetes and depression care
Description: Usual care of diabetes and depression involves providing care by the family physician based on usual standards of care and available clinical practice guidelines. Usual care does not involve additional active support from the Care Manager.
Study NCT03709251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Walking
Description: Intense walking activity at an intensity of 70-80% of the maximum heart rate
Study NCT03709251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Casual Speed Walking
Description: Moderate intensity (50-60% of Heart Rate maximum)
Study NCT00831116 — intervention group
Intervention type: DEVICE
Intervention: Intravascular Near Infrared Spectroscopy
Description: Intravascular imaging with a catheter based spectroscopy system.
Study NCT01621386 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast
Description: Administered orally as a single daily 10 mg dose for 2 weeks
Study NCT01621386 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Administered orally as a single daily 20 mg dose for 2 weeks
Study NCT03008811 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary vein isolation with cryoballoon catheter.
Description: Device: Arctic Front Advance™ cardiac cryoablation catheter system.
Study NCT03008811 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary vein isolation with radiofrequency ablation.
Description: Device: TactiCath™ Quartz irrigated ablation catheter (St. Jude Medical) with aid of 3-D mapping system (EnSite Precision, St. Jude Medical).
Study NCT00835900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: varenicline
Description: variable dosing schedule
Study NCT00835900 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT01892540 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: positron emission tomography/computed tomography
Description: Undergo PET/CT
Study NCT01892540 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/MRI
Description: Undergo PET/MRI positron emission tomography/magnetic resonance imaging hybrid imaging
Study NCT01892540 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Position Device
Study NCT05148910 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Silver and copper IUD (TCu380Ag)
Description: An intrauterine device containing 380mm² of copper with a silver core.
Study NCT05148910 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Copper IUD (TCu380A)
Description: An intrauterine device containing 380mm² of copper.
Study NCT02538952 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Xpert device
Description: Interventions in the Experimental phase of this stepped-wedge trial include: (a) ensuring WHO-recommended TB screening adopted, (b) situating trained TB case finding nurses in the clinics, (c) training clinic personnel in the TB diagnostic algorithms, and (d) activation of the Xpert diagnostic device.
Study NCT03070795 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: early feeding
Description: start oral sips four hours after cesarean section
Study NCT03070795 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: delayed feeding
Description: start oral feeding on post operation day 1 (>12hours) after surgery
Study NCT00346749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol
Study NCT00346749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone Propionate/Salmeterol Combination Product
Study NCT00933725 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TCM intervention
Description: Drug: Particle of compound Chinese herbs(produced by San_jiu Medical \& Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China), mixing with boiled water, free of decoction, taken orally, twice a day, for two months.~One tablet placebo of Tibolone (provided by San_jiu Medical \& Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China, once every two days, taken orally, for two months.~Behavioral: TCM emotion treatment: made under the guide of TCM theory, administered by qualified TCM physician, for three times in two months.
Study NCT00933725 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Western intervention
Description: Drug: Tibolone, (produced by Oujianong corporation, Nanjing, China), 2.5mg, once every two days, taken orally, for two months; Particle placebo of compound Chinese herbs (produced by San_jiu Medical \& Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China), mixing with boiled water, free of decoction, taken orally, twice a day, for two months.~Behavioral: supportive psychotherapy, administered by qualified physician, for three times in two months.
Study NCT00652847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ezetimibe
Description: ezetimibe 10 mg/day for a six week course of treatment.
Study NCT00652847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: statins
Description: patients on statins have their dose doubled for 6 weeks followed by another 6 month observational phase
Study NCT00652847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: statins
Description: patients on statins have their dose doubled for 6 weeks followed by another 6 month observational phase
Study NCT04135404 — intervention group
Intervention type: OTHER
Intervention: health-related telephone surveys
Description: The Behavioral Risk Factor Surveillance System (BRFSS) is a health-related telephone surveys that collect state data about United States residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services (Secondary-data analysis).
Study NCT02538952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intensified TB Case Finding (ICF)
Description: Interventions in the active comparator phase of this stepped wedge trial only include: (a) adoption of the WHO-recommended 4-symptom TB screen for adults; (b) situating trained TB case-finding nurses in the 22 facilities; and (c) training health facility personnel in TB diagnostic algorithms. There is no Xpert device activation in this phase. Only the standard of care microscopy algorithm (smear microscopy and chest x-ray) are available during this phase.
Study NCT02538952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensified TB Case Finding (ICF)
Description: Interventions in the active comparator phase of this stepped wedge trial only include: (a) adoption of the WHO-recommended 4-symptom TB screen for adults; (b) situating trained TB case-finding nurses in the 22 facilities; and (c) training health facility personnel in TB diagnostic algorithms. There is no Xpert device activation in this phase. Only the standard of care microscopy algorithm (smear microscopy and chest x-ray) are available during this phase.
Study NCT02667340 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Superstarch
Description: 0.7 g Superstarch or placebo per kg body mass in two ingestions (before game \& at halftime)
Study NCT02667340 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.7 g glucose per kg body mass in two ingestions (before game \& at halftime)
Study NCT04993573 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Questions about the impact of COVID-19 in their works
Study NCT04993573 — intervention group
Intervention type: OTHER
Intervention: Individual interview
Description: Discussion between the searcher and the participant about representations of COVID-19 and experiences about confinement.
Study NCT00913081 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Quercetin
Description: Quercetin 500, 1000, or 2000 mg PO one time
Study NCT00913081 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo PO one time
Study NCT02806713 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenazopyridine
Study NCT02806713 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: no Phenazopyridine
Description: Because the obvious effects on the urine coloration of pyridium no placebo or dummy are provided
Study NCT03632564 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: REVIVIEW dichoptic audio-visual stimulation
Description: REVIVIEW dichoptic audio-visual stimulation using video goggles
Study NCT02012400 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The exercise group is given a 24-week individualized training program, including aerobic exercise, muscular training, relaxation exercises and stretching. Patients are asked to observe their asthma control daily and to mark in their diary asthma symptoms and activity limitations as well as duration, intensity and form of exercising on daily basis. They are also asked to perform PEF-measurements twice a day for one-week period every 4 weeks. The control group receives ordinary instructions.